miltefosine has been researched along with Leishmaniasis, Diffuse Cutaneous in 9 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Leishmaniasis, Diffuse Cutaneous: A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Miltefosine was the first oral compound approved for visceral leishmaniasis chemotherapy, and its efficacy against Leishmania donovani has been well documented." | 1.40 | In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis. ( Coelho, AC; Costa, CH; Trinconi, CT; Uliana, SR, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kassardjian, AA | 1 |
| Yim, KM | 1 |
| Rabi, S | 1 |
| Liang, TZ | 1 |
| Kim, GH | 1 |
| Ochoa, MT | 1 |
| Sattah, MV | 1 |
| Ahronowitz, IZ | 1 |
| Coelho, AC | 1 |
| Trinconi, CT | 1 |
| Costa, CH | 1 |
| Uliana, SR | 1 |
| Kevric, I | 1 |
| Cappel, MA | 1 |
| Keeling, JH | 1 |
| Bezerra-Souza, A | 1 |
| Yamamoto, ES | 1 |
| Laurenti, MD | 1 |
| Ribeiro, SP | 1 |
| Passero, LF | 1 |
| Khandpur, S | 1 |
| Chaturvedi, P | 1 |
| Kumar, U | 1 |
| Khaitan, BK | 1 |
| Samantaray, JC | 1 |
| Sharma, VK | 1 |
| Ordaz-Farias, A | 1 |
| Muñoz-Garza, FZ | 1 |
| Sevilla-Gonzalez, FK | 1 |
| Arana-Guajardo, A | 1 |
| Ocampo-Candiani, J | 1 |
| Treviño-Garza, N | 1 |
| Becker, I | 1 |
| Camacho-Ortiz, A | 1 |
| Schraner, C | 1 |
| Hasse, B | 1 |
| Hasse, U | 1 |
| Baumann, D | 1 |
| Faeh, A | 1 |
| Burg, G | 1 |
| Grimm, F | 1 |
| Mathis, A | 1 |
| Weber, R | 1 |
| Günthard, HF | 1 |
| González, LM | 1 |
| Vélez, ID | 1 |
| Zerpa, O | 1 |
| Ulrich, M | 1 |
| Blanco, B | 1 |
| Polegre, M | 1 |
| Avila, A | 1 |
| Matos, N | 1 |
| Mendoza, I | 1 |
| Pratlong, F | 1 |
| Ravel, C | 1 |
| Convit, J | 1 |
2 reviews available for miltefosine and Leishmaniasis, Diffuse Cutaneous
| Article | Year |
|---|---|
Diffuse cutaneous leishmaniasis and HIV co-infection: A case report and review of the literature.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Darier Disease; Drug Therapy, Combination; | 2021 |
New World and Old World Leishmania Infections: A Practical Review.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations | 2015 |
7 other studies available for miltefosine and Leishmaniasis, Diffuse Cutaneous
| Article | Year |
|---|---|
In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Resistance; Female; Humans; Leishmania; | 2014 |
The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Benzylamines; Drug Repositioning; Female; Leishman | 2016 |
Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Viscer | 2010 |
Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana.
Topics: Antiprotozoal Agents; Humans; Leishmania mexicana; Leishmaniasis, Diffuse Cutaneous; Phosphorylcholi | 2013 |
Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1.
Topics: Adult; Antiprotozoal Agents; HIV Infections; Humans; Immunocompromised Host; Leishmaniasis, Diffuse | 2005 |
[Miltefosine for disseminated cutaneous leishmaniasis].
Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Diffuse Cutaneous; Male; Phosphorylcholine | 2006 |
Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Resistance; Female; Humans; L | 2007 |